Objective: The purpose of this study was to provide a viable alternative to routine postpartum hematocrit measurement, by a determination of the clinical risk factors that identify patients with
with hematocrit levels of <23% was also evaluated because this was felt to be a more clinically significant cutoff point.
This study is a retrospective review of the hospital records. Preliminarily, all vaginal deliveries from January 1995 through January 1998 were analyzed to ascertain a baseline postpartum transfusion rate for our patient population. The study was then limited to the most recent time period during which enough cases occurred to give sufficient power to analyze risk factors. Cases were defined as those women who had vaginal delivery between the months of February 1997 and July 1998 and who had a first-day postpartum hematocrit level of <26%. The research team reviewed the written hospital records to verify criteria for inclusion in the study. Control subjects were defined as women who had vaginal delivery and who had a first-day postpartum hematocrit level of 26%. Two control subjects per case were assigned. Control subjects were selected from women who were delivered just before and just after each case to account for changes in medical practice over time and variation among practitioners.
A professional nurse research assistant abstracted data from the written medical record. Questionable notations were forwarded to the principal investigator for a final decision on acceptability. Demographic variables included age, payer type (private insurance, Medicaid, or self-insured), and race (white, African American, Hispanic, Asian, American Indian, or other as selected by the patient on admission to the hospital). Medical history variables were gravidity, parity, and previous hemorrhage. Potential indicators of low hematocrit levels that were collected from the nursing assessment record included heart rate and blood pressure that was recorded on the first day after delivery, complaint of dizziness or inability to ambulate, and oliguria (defined as <30 mL/h). Medical risk factors were chosen from those identified in previous studies. The association of each of the demographic variables, medical history variables, medical risk factors, and the variables with low hematocrit levels that were collected from the nursing assessment record were tested with the use of the Wilcoxon 2-sample test for the continuous variables and the Fisher exact test or χ 2 test for the categoric variables. The variables (age, race, estimated blood loss, heart rate, diastolic blood pressure, pulse pressure, gravidity, parity, laceration degree, uterine atony, laceration type, multiple gestation, retained placenta, prolonged third stage, use of forceps, use of vacuum, complaint of dizziness, and inability to ambulate) that had a probability value of <.10 from this initial univariate analysis were included in the multivariate stepwise logistic regression analysis to determine the best set of risk factors and indicators for the identification of low hematocrit levels on the first day after delivery. Continued inclusion in the multivariate stepwise logistic regression model required a probability value of <.1. All of the statistical analyses were performed with the SAS/STAT software (SAS version 7; SAS Institute Inc, Cary, NC).
Results
From January 1995 to January 1998, 3178 vaginal deliveries occurred. Of 25 total transfusions (0.8%), 6 transfusions occurred after the routine postpartum hematocrit measurement (0.19%). During the study period (February 1997 to July 1998), there were 1484 vaginal deliveries. There were 11 total transfusions (0.7%), 4 of which occurred after the routine postpartum hematocrit measurement (0.27%). A first-day postpartum hematocrit level of <26% was found in 117 women (8%); 198 controls were assigned for comparison. Occasionally, there was duplication of control subjects for cases, as when 2 cases followed each other in time, which resulted in slightly fewer than 2 control subjects for every case.
Group comparisons for demographic and prelabor characteristics are summarized in Table I . There were significant differences for age, gravidity, parity, and race. Cases were slightly younger and had fewer previous pregnancies than control subjects. The case group also showed a significantly higher number of Hispanic women. Comparisons for labor and delivery and postpartum characteristics are shown in Table II . The variables "retained placenta" and "blood dyscrasia" each showed significant group differences but were not entered into the regression because of the small number of cases and control subjects who were affected.
Six variables were retained in the initial model: estimated blood loss, race, dizziness, laceration degree, forceps, and age. Quartiles of the distributions were examined for possible categorization of the variables estimated blood loss, age, and laceration degree. To make the estimated blood loss factor more clinically useful, the data were categorized as estimated blood loss of 500 mL and estimated blood loss of >500 mL. Degree of laceration was reduced to 3 categories: (1) none, (2) first or second, and (3) third, fourth, or multiple. Age was kept as a continuous variable, with the odds ratio expressed as a 5-year age difference.
The resulting logistic regression model is shown in Table III .
Four variables retained highly significant probability values: estimated blood loss of >500 mL; Hispanic race; dizziness; and 3rd-degree, 4th-degree, or multiple lacerations. The presence of at least 1 of these 4 variables identified 82.9% of the cases (97/117 cases). In the control group, 35.6% (68/191 control subjects) had at least 1 risk factor (Table IV) .
Only 39.3% of patients would have required a postpartum hematocrit measurement to identify these cases (derived from the percentage of control subjects with 4 risk factors plus the percentage with <26% Because only 4 women had received a transfusion for low hematocrit levels during the 18-month study period, the research team re-evaluated the definition of a clinically significant low hematocrit level. A value of <23% was determined to be a clinically significant value. Thirty-eight of the original 117 cases had hematocrit levels of <23%. The predictive value of risk factors was re-evaluated for this subgroup of patients. The presence of at least 1 risk factor (estimated blood loss of >500 mL, Hispanic race, complaint of dizziness, or 3rd-degree, 4th-degree, or multiple lacerations) identified 37 of the 38 women (97.4%) with hematocrit levels of <23% (Table IV) .
Charts were later reviewed to determine whether the risk for the Hispanic population occurred because of an increased rate of pre-existing anemia compared with non-Hispanic patients. Although prenatal hematocrit values were unavailable for all cases and control subjects, we were able to determine that 33% of Hispanics had hematocrit levels of 30% from 36 weeks until delivery. Only 23% of nonHispanic women had decreased hematocrit levels before delivery.
Comment
We found that using 4 risk factors (estimated blood loss of > 500 mL, Hispanic ethnicity, complaint of dizziness, or high-degree laceration), we could detect 82.9% and 97.4% of patients who were anemic, where anemia was defined as hematocrit levels of <26% and <23%, respectively. Only 39.3% of the patients would have required postpartum hematocrit measurement. Three risk factors (estimated blood loss, Hispanic ethnicity, and dizziness) identified 75% of patients with hematocrit levels of <26% and 94.7% of patients with hematocrit levels of <23%. To obtain this detection rate, only 30.7% of vaginal delivery patients would have required postpartum hematocrit studies.
Several studies have concluded that the volume of blood that is lost during delivery is the best indicator of postpartum hematocrit level. Both Nicol et al [1] and Swaim et al [3] noted high estimated blood loss as the factor that is associated most often with postpartum anemia. Estimated blood loss is routinely documented after delivery, and although the method of estimating volume loss is not standardized, Reis et al [2] showed that increased volume loss that is documented at delivery directly correlates with decreased hematocrit after delivery. This study confirms that observation, because >68% of the severely anemic patients (hematocrit level, <23%) were identified by estimated blood loss of >500 mL alone.
Although Hispanic ethnicity was not identified as a risk factor in previous studies, several investigations point to a disparity in iron status among ethnic groups. The Ten State Nutrition Survey (1968) (1969) (1970) indicated an increased iron-deficiency anemia rate among Mexican American and Puerto Rican patients, compared with European American patients. [7] Another study [8] found a disparity in mean corpuscular volume specifically between Hispanic and white women aged 20 to 44 years. Increased pernicious anemia rates exist among young Latin American women, [9] and an increased prevalence of anemia and subsequent preterm delivery are evident, despite iron supplementation. [10] Although none of these studies were able to determine the cause of increased anemia rates, hypotheses include nutritional deficit, genetic predisposition, or lack of prenatal care when at-risk women can be identified.
Prenatal hematocrit values were not originally part of this investigation; however, the disparity among Hispanic women prompted further investigation to determine whether pre-existing anemia played a role in the increased risk of postpartum anemia. Although prenatal hematocrit levels were obtained at clinician preference, comparison at similar gestational ages showed a trend toward increased preexisting anemia among the Hispanic cases. Whether this trend is due to a lack of prenatal iron supplementation, nutritional deficiencies, or a genetic predisposition to anemia remains undetermined. Determining the cause of ethnic anemic disparity warrants further investigation. Hispanic ethnicity is a risk factor for postpartum anemia in our population.
Several causes exist for a patient complaint of dizziness, including vasodilation after epidural, vasovagal effects, extravasation, and others. When dizziness is caused by anemia, it is associated usually with more significant decreases in hematocrit levels. Because of decreasing oxygen delivery, patients with severe anemia report shortness of breath, headache, palpitations, and dizziness. Although compensation normally occurs with mild anemia, even modest decreases in total blood volume (such as occur in acute blood loss) will interfere with the cardiovascular response. [11] Dizziness clearly detected patients who were at risk for low hematocrit levels and introduced a clinical symptom of anemia into our identification scheme. This is significant because typical practice dictates that asymptomatic anemia not be transfused unless hematocrit values fall into the teens or unless additional bleeding is anticipated. [4] The prevalence of anemia (hematocrit level, <26%) among vaginal deliveries was approximately 8%. Only 0.7% of patients received a transfusion. Further, 0.27% of patients received transfusion subsequent to the routine hematocrit determination. Clearly, positive clinical symptoms are used along with hematocrit values in the decision to transfuse a patient with anemia. [12] In the studies of both Nicol et al [1] and Reis et al, [2] no clinical symptoms were used to identify anemic patients. Although Swaim et al [3] did investigate orthostatic blood pressure determinations, the study did not attempt to associate a physical symptom of anemia with the actual number of patients with anemia in the population.
Reis et al [2] and Nicol et al [1] both associated high-degree laceration with low postpartum hematocrit levels, but the identification scheme of Nicol et al picked up only 82% of the patients with anemia when all their risk factors were used. Although one might think laceration is associated with increased blood loss at delivery, these 2 variables had independent significant probability values in our study and were not necessarily present in conjunction with one another. This lack of association could indicate an underestimation of blood loss, especially in cases in which larger volumes are lost because of complications such as perineal laceration. The use of high-degree laceration as a risk factor in addition to increased estimated blood loss could potentially identify patients whose increased blood loss was not picked by the visual estimation at the time of delivery.
This study concurs with previous investigations in the finding of specific risk factors that are associated with postpartum anemia. However, we used fewer risk factors to identify a higher percentage of patients with anemia than any previous study (Table V) . Table V . Comparison of studies on the usefulness of routine postpartum hematocrit measurement Nicol et al [1] Reis et al [2] Swaim et al [3] Current study Definition Although Reis et al [2] did find an association between laceration and the use of forceps with anemia, the study did not give positive predictive values for either risk factor. The approach of Swaim et al [3] to the assessment of anemia included both clinical factors and physician discretion to identify high-risk patients who would undergo hematocrit determination. Unfortunately, without obtaining hematocrit levels for low-risk patients, it is impossible to determine whether any patients with anemia were missed with their identification scheme. In addition, physician discretion cannot be standardized as a risk factor for identification. Although Nicol et al [1] investigated independent risk factors that occur along with low postpartum hematocrit levels, the long list of factors is onerous and cannot effectively replace a single laboratory test. We addressed the shortcomings of each of the previous studies and developed a simple, objective method to identify high-risk patients for whom postpartum hematocrit measurements are indicated.
We identified 37 of 38 patients with hematocrit levels of <23% using 4 objective risk factors (Table IV) . Although these risk factors failed to pick up 1 patient, the patient had a hematocrit value of 22%, a value at which transfusion is not indicated without clinical symptoms of anemia. The United States Report of Health and Human Services' guidelines for the use of blood products states that adequate cardiopulmonary function can be met by a hematocrit level of 21%. [12] Furthermore, in a recent study of transfusion strategies, no difference was found in the postoperative recovery of patients with hematocrit levels of 21% and 30%. [4] In addition to the fact that the patient's anemia was not clinically significant, this patient was delivered for preeclampsia and would probably have had a complete blood workup after delivery. Thus, her anemia would have been monitored regardless of whether the postpartum hematocrit measurement remained a routine practice.
During the study period, 11 patients received blood transfusions subsequent to delivery. Seven of these transfusions occurred immediately after delivery at the discretion of the physician, because of patient hypotension, loss of consciousness, or symptomatic loss of blood volume. Four patients received transfusion subsequent to the routine postpartum hematocrit measurement. All 4 patients had dizziness; 3 patients had estimated blood loss of >500 mL, and 2 patients had third-degree laceration. All 4 patients also had hematocrit levels of 22% (22%, 22%, 21%, and 17%). Each patient would have been identified if risk factors had been substituted for routine postpartum hematocrit measurement.
Identifying potentially anemic patients with this strategy instead of the routine postpartum hematocrit measurement would have eliminated blood draws for 60.7% of patients who had vaginal delivery. In addition to decreasing the risk of blood-borne infection among patients and staff and increasing patient satisfaction by eliminating a painful procedure, this translates into $1351 savings per 100 vaginal deliveries ($9.50/hematocrit measurement + $12.75/phlebotomy at our institution).
This study was performed retrospectively, and our identification scheme should be studied prospectively to confirm the findings. Although our risk factors picked up all but 2.6% of the patients with anemia (defined as a hematocrit level of <23%), there may be other clinical criteria, such as orthostatic vital signs, which could be added to increase sensitivity and specificity. We acknowledge that our sample size is small, which makes the applicability of generalizing the conclusions more suspect. The demographics in a midwestern medical center may not be representative of those in medical centers that serve different populations. One could hypothesize that the use of our model in urban, inner city, or otherwise ethnically more diverse populations may alter the accuracy. Also, patients at a teaching hospital may not be representative of patients in private practice. In spite of these limitations, this study indicates that it is possible to develop a definitive clinical identification scheme to replace the routine postpartum hematocrit measurement without compromising the standard of patient care. Our results could be put into clinical practice by obtaining postpartum hematocrit levels from only those patients with 1 or more of the 4 risk factors. This would identify most patients with anemia who require transfusion or special discharge instructions (including additional iron sulfate supplementation). Certainly patients with other underlying conditions, such as pregnancy-induced hypertension or preeclampsia, who do not typically expand their intravascular volume in comparison with their normal counterparts, should continue to receive postpartum hematocrit measurements or other laboratory assessments.
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